An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis

Journal of Leukocyte Biology

Volumn 96, Issue 3, 2014, Pages 463-472

  Ramani, Kritika ^a   Pawaria, Sudesh ^a   Maers, Kelly ^a   Huppler, Anna R ^a,b   Gaffen, Sarah L ^a   Biswas, Partha S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

IL 17; Inflammation; Kidney

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17F; CYTOKINE; IL17R PROTEIN, MOUSE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FILTERS AND MEMBRANES; FLUORESCENCE ACTIVATED CELL SORTING; GENE TARGETING; GLOMERULONEPHRITIS; IMMUNE COMPLEX DEPOSITION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IN VITRO STUDY; INFLAMMATORY CELL; KIDNEY CORTEX; KIDNEY PARENCHYMA; LOW DRUG DOSE; LYMPH NODE; MOUSE; NEPHRITIS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DRUG EFFECTS; DRUG POTENTIATION; EPITHELIUM CELL; FEMALE; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; KIDNEY TUBULE; KNOCKOUT MOUSE; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DRUG SYNERGISM; EPITHELIAL CELLS; FEMALE; INTERLEUKIN-17; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTORS, INTERLEUKIN-17; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84907329820     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0414-184R     Document Type: Article

References (35)

1. Kambham, N. (2012) Crescentic glomerulonephritis: an update on pauci-immune and anti-GBM diseases. Adv. Anat. Pathol. 19, 111-124.
2. Kulkarni, O. P., Anders, H. J. (2012) Lupus nephritis. How latest insights into its pathogenesis promote novel therapies. Curr. Opin. Rheuma-tol. 24, 457-465.
3. Srivastava, A., Rao, G. K., Segal, P. E., Shah, M., Geetha, D. (2013) Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Clin. Rheumatol. 32, 1317-1322.
4. Kewalramani, R., Singh, A. K. (2002) Immunopathogenesis of lupus and lupus nephritis: recent insights. Curr. Opin. Nephrol. Hypertens. 11, 273-277.
5. Tipping, P. G., Kitching, A. R., Cunningham, M. A., Holdsworth, S. R. (1999) Immunopathogenesis of crescentic glomerulonephritis. Curr. Opin. Nephrol. Hypertens. 8, 281-286.
6. Makker, S. P. (1993) Mediators of immune glomerular injury. Am. J. Nephrol. 13, 324-336.
7. Awasthi, A., Kuchroo, V. K. (2009) Th17 cells: from precursors to players in inflammation and infection. Int. Immunol. 21, 489-498.
8. Veldhoen, M. (2009) The role of T helper subsets in autoimmunity and allergy. Curr. Opin. Immunol. 21, 606-611.
9. Zhang, Z., Kyttaris, V. C., Tsokos, G. C. (2009) The role of IL-23/IL-17 axis in lupus nephritis. J. Immunol. 183, 3160-3169.
10. Turner, J. E., Paust, H. J., Steinmetz, O. M., Panzer, U. (2010) The Th17 immune response in renal inflammation. Kidney Int. 77, 1070-1075.
11. Gan, P. Y., Steinmetz, O. M., Tan, D. S., O'Sullivan, K. M., Ooi, J. D., Iwakura, Y., Kitching, A. R., Holdsworth, S. R. (2010) Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J. Am. Soc. Nephrol. 21, 925-931.
12. Ooi, J. D., Phoon, R. K., Holdsworth, S. R., Kitching, A. R. (2009) IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J. Am. Soc. Nephrol. 20, 980-989.
13. Gaffen, S. L. (2009) Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9, 556-567.
14. Cua, D. J., Tato, C. M. (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489.
15. Gaffen, S. L. (2011) Recent advances in the IL-17 cytokine family. Curr. Opin. Immunol. 23, 613-619.
16. Gaffen, S. L. (2008) An overview of IL-17 function and signaling. Cyto-kine 43, 402-407.
17. Kitching, A. R., Holdsworth, S. R. (2011) The emergence of TH17 cells as effectors of renal injury. J. Am. Soc. Nephrol. 22, 235-238.
18. Nalbandian, A., Crispin, J. C., Tsokos, G. C. (2009) Interleukin-17 and systemic lupus erythematosus: current concepts. Clin. Exp. Immunol. 157, 209-215.
19. Paust, H. J., Turner, J. E., Steinmetz, O. M., Peters, A., Heymann, F., Holscher, C., Wolf, G., Kurts, C., Mittrucker, H. W., Stahl, R. A., Panzer, U. (2009) The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20, 969-979.
20. Pisitkun, P., Ha, H. L., Wang, H., Claudio, E., Tivy, C. C., Zhou, H., Mayadas, T. N., Illei, G. G., Siebenlist, U. (2012) Interleukin-17 cyto-kines are critical in development of fatal lupus glomerulonephritis. Immunity 37, 1104-1115.
21. Qian, Y., Qin, J., Cui, G., Naramura, M., Snow, E. C., Ware, C. F., Fairchild, R. L., Omori, S. A., Rickert, R. C., Scott, M., Kotzin, B. L., Li, X. (2004) Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21, 575-587.
22. Giltiay, N. V., Lu, Y., Cullen, J. L., Jorgensen, T. N., Shlomchik, M. J., Li, X. (2013) Spontaneous loss of tolerance of autoreactive B cells in Act1-deficient rheumatoid factor transgenic mice. J. Immunol. 191, 2155-2163.
23. Qian, Y., Giltiay, N., Xiao, J., Wang, Y., Tian, J., Han, S., Scott, M., Carter, R., Jorgensen, T. N., Li, X. (2008) Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren's syndrome. Eur. J. Immunol. 38, 2219-2228.
24. Fu, Y., Du, Y., Mohan, C. (2007) Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin. Immunol. 124, 109-118.
25. O'Connor Jr., W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., Flavell, R. A. (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603-609.
26. Hsu, H. C., Yang, P., Wang, J., Wu, Q., Myers, R., Chen, J., Yi, J., Guent-ert, T., Tousson, A., Stanus, A. L., Le, T. V., Lorenz, R. G., Xu, H., Kolls, J. K., Carter, R. H., Chaplin, D. D., Williams, R. W., Mountz, J. D. (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9, 166-175.
27. Onishi, R. M., Gaffen, S. L. (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129, 311-321.
28. Forlow, S. B., Schurr, J. R., Kolls, J. K., Bagby, G. J., Schwarzenberger, P. O., Ley, K. (2001) Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 98, 3309-3314.
29. Liu, B., Tan, W., Barsoum, A., Gu, X., Chen, K., Huang, W., Ramsay, A., Kolls, J. K., Schwarzenberger, P. (2010) IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement. Exp. Hematol. 38, 877.e1-884.e1.
30. Muller, G. A., Markovic-Lipkovski, J., Frank, J., Rodemann, H. P. (1992) The role of interstitial cells in the progression of renal diseases. J. Am. Soc. Nephrol. 2, S198-S205.
31. Radeke, H. H., Resch, K. (1992) The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system. Clin. Investig. 70, 825-842.
32. Kelley, V. R., Singer, G. G. (1993) The antigen presentation function of renal tubular epithelial cells. Exp. Nephrol. 1, 102-111.
33. Herber, D., Brown, T. P., Liang, S., Young, D. A., Collins, M., Dunussi-Joannopoulos, K. (2007) IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R. Fc reduces disease progression. J. Immunol. 178, 3822-3830.
34. Liang, B., Gardner, D. B., Griswold, D. E., Bugelski, P. J., Song, X. Y. (2006) Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology 119, 296-305.
35. Miossec, P., Kolls, J. K. (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763-776.